{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:06:09Z","timestamp":1778155569103,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd009038","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T00:00:00Z","timestamp":1320796800000}}],"reference-count":22,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009038.pub2","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T18:21:51Z","timestamp":1320171711000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Quadriphasic versus monophasic oral contraceptives for contraception"],"prefix":"10.1002","author":[{"given":"Huib AAM","family":"Van Vliet","sequence":"first","affiliation":[{"name":"Leiden University Medical Center; Department of Gynaecology, Division of Reproductive Medicine; PO Box 9600 Albinusdreef 2 Leiden Netherlands NL 2300 RC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein","family":"Raps","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Epidemiology; PO Box 9600 Albinusdreef 2 Leiden Netherlands NL 2300 RC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laureen M","family":"Lopez","sequence":"additional","affiliation":[{"name":"FHI 360; Clinical Sciences; P.O. Box 13950 Research Triangle Park North Carolina USA 27709"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans M","family":"Helmerhorst","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Gynaecology, Division of Reproductive Medicine and Dept. of Clinical Epidemiology; PO Box 9600 Albinusdreef 2 Leiden Netherlands NL 2300 RC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,11,9]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD009038.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.contraception.2009.03.018","article-title":"Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel","volume":"80","author":"Ahrendt","year":"2009","journal-title":"Contraception"},{"issue":"s2 Book of Abst","key":"10.1002\/14651858.CD009038.pub2-BIB0002|cit2","first-page":"94","article-title":"Bleeding patterns and cycle control with a novel four-phasic combined oral contraceptive containing estradiol valerate and dienogest","volume":"13","author":"Parke","year":"2008","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"issue":"7","key":"10.1002\/14651858.CD009038.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009038.pub2-BIB0004|cit4","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]","author":"Higgings","year":"2009"},{"issue":"1","key":"10.1002\/14651858.CD009038.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2009.08.010","article-title":"Review of clinical experience with estradiol in combined oral contraceptives","volume":"81","author":"Fruzzetti","year":"2010","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD009038.pub2-BIB0006|cit6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003989","article-title":"20 \u00b5g versus >20 \u00b5g estrogen combined oral contraceptives for contraception","author":"Gallo","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD009038.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2165\/11202820-000000000-00000","article-title":"Estradiol valerate\/dienogest in oral contraception","volume":"69","author":"Hoy","year":"2009","journal-title":"Drugs"},{"issue":"7","key":"10.1002\/14651858.CD009038.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1517\/14656561003724713","article-title":"Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest","volume":"11","author":"Jensen","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"7400","key":"10.1002\/14651858.CD009038.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD009038.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1783\/147118909788707878","article-title":"Qlaira: a 'natural' change of direction","volume":"35","author":"Mansour","year":"2009","journal-title":"Journal of Family Planning and Reproductive Health Care"},{"key":"10.1002\/14651858.CD009038.pub2-BIB0011|cit11","unstructured":"Nelson A Sampson-Landers C Parke S Jensen J Efficacy of estradiol valerate\/dienogest OC: results of 3 large studies in North America and Europe Presented at the 57th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, 2-6 May 2009, Chicago, IL, USA"},{"issue":"1","key":"10.1002\/14651858.CD009038.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2009.11.001","article-title":"Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate\/dienogest): a phase III trial","volume":"149","author":"Palacios","year":"2010","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009038.pub2-BIB0013|cit13","first-page":"i78","article-title":"Comparative effects of a four-phasic regimen of estradiol valerate\/dienogest versus ethinylestradiol\/levonorgestrel on haemostatic parameters","volume":"23","author":"Parke","year":"2008","journal-title":"Human Reproduction Update"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD009038.pub2-BIB0014|cit14","first-page":"12","article-title":"Metabolic effects of a new four-phasic oral contraceptive containing estradiol valerate and dienogest","volume":"111","author":"Parke","year":"2008","journal-title":"Obstetrics & Gynecology"},{"issue":"106","key":"10.1002\/14651858.CD009038.pub2-BIB0015|cit15","first-page":"65","article-title":"Oral contraception: estradiol does not provide a therapeutic advantage","volume":"19","author":"Prescrire International","year":"2010","journal-title":"Prescrire International"},{"key":"10.1002\/14651858.CD009038.pub2-BIB0016|cit16","unstructured":"Bayer HealthCare Qlaira website www.qlaira.nl"},{"key":"10.1002\/14651858.CD009038.pub2-BIB0017|cit17","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"5","key":"10.1002\/14651858.CD009038.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"9308","key":"10.1002\/14651858.CD009038.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(02)07882-0","article-title":"Sample size slippages in randomised trials: exclusions and the lost and wayward","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009038.pub2-BIB0020|cit20","volume-title":"A Clinical Guide for Contraception","author":"Speroff","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD009038.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003989","article-title":"Biphasic versus monophasic oral contraceptives for contraception","author":"Vliet","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009038.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003989","article-title":"Triphasic versus monophasic oral contraceptives for contraception","author":"Vliet","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009038.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:27:04Z","timestamp":1628548024000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD009038.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Fertility Regulation Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,11,9]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009038.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,9]]}}}